Table 4.
Summary of 95% confidence intervals (CI) and P values for the pharmacokinetic parameters of ziprasidone on day 8.
| AUC(0,12 h) Ratio of geometric means (%) | Cmax Ratio of geometric means (%) | tmax | ||||
|---|---|---|---|---|---|---|
| Day 8 | 95% CI | P value | 95% CI | P value | 95% CI | P value |
| Normal vs mildly impaired renal function | 50,94 | 0.0221 | 53,103 | 0.0724 | −2,1 | 0.4705 |
| Normal vs moderately impaired renal function | 83,158 | 0.3857 | 91,179 | 0.1520 | −2,1 | 0.7721 |
| Normal vs severely impaired renal function | 76,144 | 0.7784 | 70,138 | 0.9291 | −2,1 | 0.3143 |
| Mildly impaired vs moderately impaired renal function | 122,230 | 0.0025 | 124,243 | 0.0022 | −1,2 | 0.6642 |
| Mildly impaired vs severely impaired renal function | 111,210 | 0.0113 | 96,188 | 0.0865 | −2,1 | 0.7721 |
| Moderately impaired vs severely impaired renal function | 66,125 | 0.5556 | 55,108 | 0.1292 | −2,1 | 0.4705 |